| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3770638
[patent_doc_number] => 05807700
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Method of screening anti-amebic agents with an E. coli mutant having a deleted adhE gene complemented by the E. histolytica EhADH2 gene'
[patent_app_type] => 1
[patent_app_number] => 8/562969
[patent_app_country] => US
[patent_app_date] => 1995-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5427
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807700.pdf
[firstpage_image] =>[orig_patent_app_number] => 562969
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/562969 | Method of screening anti-amebic agents with an E. coli mutant having a deleted adhE gene complemented by the E. histolytica EhADH2 gene | Nov 26, 1995 | Issued |
Array
(
[id] => 3737768
[patent_doc_number] => 05753449
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Method of and apparatus for determining hydrogen peroxide by raman scattering'
[patent_app_type] => 1
[patent_app_number] => 8/563112
[patent_app_country] => US
[patent_app_date] => 1995-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 3504
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753449.pdf
[firstpage_image] =>[orig_patent_app_number] => 563112
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/563112 | Method of and apparatus for determining hydrogen peroxide by raman scattering | Nov 26, 1995 | Issued |
Array
(
[id] => 4007676
[patent_doc_number] => 05879682
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Aframonum seeds for improving penile activity'
[patent_app_type] => 1
[patent_app_number] => 8/562558
[patent_app_country] => US
[patent_app_date] => 1995-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/879/05879682.pdf
[firstpage_image] =>[orig_patent_app_number] => 562558
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/562558 | Aframonum seeds for improving penile activity | Nov 23, 1995 | Issued |
Array
(
[id] => 4041489
[patent_doc_number] => 05911986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Foodstuffs and other compositions'
[patent_app_type] => 1
[patent_app_number] => 8/464660
[patent_app_country] => US
[patent_app_date] => 1995-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3713
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/911/05911986.pdf
[firstpage_image] =>[orig_patent_app_number] => 464660
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464660 | Foodstuffs and other compositions | Nov 16, 1995 | Issued |
| 08/548075 | HEPOBLASTS AND METHOD OF ISOLATING SAME | Oct 24, 1995 | Abandoned |
Array
(
[id] => 3625800
[patent_doc_number] => 05686252
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Immunoassay method utilizing zeta potential and immunoassay kit'
[patent_app_type] => 1
[patent_app_number] => 8/513956
[patent_app_country] => US
[patent_app_date] => 1995-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2060
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686252.pdf
[firstpage_image] =>[orig_patent_app_number] => 513956
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/513956 | Immunoassay method utilizing zeta potential and immunoassay kit | Oct 22, 1995 | Issued |
| 08/545496 | VITAMIN B12 RECEPTOR MODULATING AGENTS CONTAINING RIBOSE ETHER LINKAGES AND METHODS RELATED THERETO | Oct 18, 1995 | Abandoned |
Array
(
[id] => 3787520
[patent_doc_number] => 05840712
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Water soluble vitamin B.sub.12 receptor modulating agents and methods related thereto'
[patent_app_type] => 1
[patent_app_number] => 8/545151
[patent_app_country] => US
[patent_app_date] => 1995-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 35201
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840712.pdf
[firstpage_image] =>[orig_patent_app_number] => 545151
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/545151 | Water soluble vitamin B.sub.12 receptor modulating agents and methods related thereto | Oct 18, 1995 | Issued |
Array
(
[id] => 4023354
[patent_doc_number] => 05882935
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Analysis element and method for analyzing glycated hemoglobin content ratio'
[patent_app_type] => 1
[patent_app_number] => 8/544133
[patent_app_country] => US
[patent_app_date] => 1995-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10897
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/882/05882935.pdf
[firstpage_image] =>[orig_patent_app_number] => 544133
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/544133 | Analysis element and method for analyzing glycated hemoglobin content ratio | Oct 16, 1995 | Issued |
Array
(
[id] => 3873582
[patent_doc_number] => 05747262
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Neurological drug screens'
[patent_app_type] => 1
[patent_app_number] => 8/551874
[patent_app_country] => US
[patent_app_date] => 1995-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1488
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747262.pdf
[firstpage_image] =>[orig_patent_app_number] => 551874
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/551874 | Neurological drug screens | Oct 15, 1995 | Issued |
Array
(
[id] => 3759205
[patent_doc_number] => 05741652
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Anti-human type IV collagen antibodies and use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/536740
[patent_app_country] => US
[patent_app_date] => 1995-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 8604
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741652.pdf
[firstpage_image] =>[orig_patent_app_number] => 536740
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/536740 | Anti-human type IV collagen antibodies and use thereof | Sep 28, 1995 | Issued |
Array
(
[id] => 4044778
[patent_doc_number] => 05869261
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Optical immunity measurement method and apparatus therefor'
[patent_app_type] => 1
[patent_app_number] => 8/428136
[patent_app_country] => US
[patent_app_date] => 1995-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4960
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869261.pdf
[firstpage_image] =>[orig_patent_app_number] => 428136
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/428136 | Optical immunity measurement method and apparatus therefor | Aug 29, 1995 | Issued |
| 08/454185 | LIPASE-LABELLED PROBE | Aug 2, 1995 | Abandoned |
| 08/497357 | PROCESS FOR IDENTIFYING PHARMACEUTICALLY ACTIVE AGENTS | Jun 29, 1995 | Abandoned |
Array
(
[id] => 3736419
[patent_doc_number] => 05785975
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Adjuvant compositions and vaccine formulations comprising same'
[patent_app_type] => 1
[patent_app_number] => 8/494969
[patent_app_country] => US
[patent_app_date] => 1995-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4854
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/785/05785975.pdf
[firstpage_image] =>[orig_patent_app_number] => 494969
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/494969 | Adjuvant compositions and vaccine formulations comprising same | Jun 25, 1995 | Issued |
Array
(
[id] => 3876745
[patent_doc_number] => 05804446
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Blood-borne mesenchymal cells'
[patent_app_type] => 1
[patent_app_number] => 8/488111
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9014
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804446.pdf
[firstpage_image] =>[orig_patent_app_number] => 488111
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488111 | Blood-borne mesenchymal cells | Jun 6, 1995 | Issued |
| 08/477424 | CARBOHYDRATE-MEDIATED COUPLING OF PEPTIDES TO IMMUNOGLOBULINS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3804396
[patent_doc_number] => 05811098
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Antibodies to HER4, human receptor tyrosine kinase'
[patent_app_type] => 1
[patent_app_number] => 8/484438
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 52
[patent_no_of_words] => 32479
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811098.pdf
[firstpage_image] =>[orig_patent_app_number] => 484438
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484438 | Antibodies to HER4, human receptor tyrosine kinase | Jun 6, 1995 | Issued |
| 08/474673 | METHOD FOR OBTAINING RECEPTOR AGONIST ANTIBODIES | Jun 6, 1995 | Abandoned |
| 08/469387 | ANALOGS OF BOTULINUM TOXIN AND PHARMACEUTICAL COMPOSITIONS OF BOTULINUM TOXIN | Jun 5, 1995 | Abandoned |